Ionis Pharmaceuticals, Inc. (IONS) FY2026 Q2 Statement of Cash Flows
2026-04-01 to 2026-06-30
Statement of Cash Flows
2026-04-01 to 2026-06-30
Swipe to see the full flow
Chart details
Ionis Pharmaceuticals, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026
Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Mar 31, 2026
- 173,381,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 565,531,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Escrow deposit for maturity of 0 percent convertible senior notes due April 2026), so those amounts cannot be separated for this quarter. It may combine inflows and outflows.
- Net loss
- negative 114,646,000 US dollars
- Depreciation
- 3,433,000 US dollars
- Amortization of right-of-use operating lease assets
- 3,505,000 US dollars
- Amortization of other assets
- 700,000 US dollars
- Amortization of debt issuance costs
- 1,801,000 US dollars
- Non-cash interest related to sale of future royalties
- 17,354,000 US dollars
- Stock-based compensation expense
- 45,595,000 US dollars
- Non-cash losses related to other assets
- 441,000 US dollars
- Accounts payable
- 21,678,000 US dollars
- Income taxes
- 3,000 US dollars
- Accrued compensation
- 14,244,000 US dollars
- Accrued liabilities and other liabilities
- negative 8,152,000 US dollars
- Deferred contract revenue
- negative 8,077,000 US dollars
- Amortization of discount on investments, net
- negative 3,343,000 US dollars
- Non-cash royalty revenue related to sale of royalties
- negative 10,698,000 US dollars
- Loss (gain) on investments, net
- 10,182,000 US dollars
- Contracts receivable
- 14,839,000 US dollars
- Inventories
- negative 24,964,000 US dollars
- Other current and long-term assets
- negative 30,875,000 US dollars
- Remaining operating cash flows, net (calculated)
- 632,511,000 US dollars
- Investing activities
- 23,497,000 US dollars. Net cash provided.
- Proceeds from sale of short-term investments
- 361,981,000 US dollars
- Purchases of short-term investments
- negative 320,250,000 US dollars
- Purchases of property, plant and equipment
- negative 16,080,000 US dollars
- Acquisition of licenses and other assets, net
- negative 2,154,000 US dollars
- Financing activities
- negative 412,294,000 US dollars. Net cash used.
- Proceeds from issuance of common stock through equity plans, net
- 20,258,000 US dollars
- Repayment of 0 percent convertible senior notes due 2026
- negative 432,511,000 US dollars
- Principal payments on mortgage debt
- negative 41,000 US dollars
- Operating adjustment reconciliation
- 766,286,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- financing gross reconciliation
- 432,552,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 361,981,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- negative 50,000 US dollars
- Ending cash on Jun 30, 2026
- 350,065,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 762,409,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 176,684,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- Operating cash flow
- 565,531,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 16,080,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 549,451,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$114.65M + net operating adjustments $680.18M = operating cash +$565.53M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 565,531,000 US dollars minus 16,080,000 US dollars equals 549,451,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!